AMELIA STEVENS: Open Payments
NPI 1467970715 · WINCHESTER, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,379 in 98 payments from 21 companies in 2025. Trend: 2023 $1,297 · 2024 $1,580 · 2025 $1,379
Food & beverage: $1,379
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 39 | $339 |
| Lilly USA, LLC | 13 | $232 |
| AstraZeneca Pharmaceuticals LP | 8 | $117 |
| PFIZER INC. | 6 | $98 |
| GlaxoSmithKline, LLC. | 5 | $96 |
| Novo Nordisk Inc | 5 | $90 |
| Novartis Pharmaceuticals Corporation | 5 | $85 |
| Axsome Therapeutics, Inc. | 2 | $39 |
| Abbott Laboratories | 2 | $36 |
| Phathom Pharmaceuticals, Inc. | 2 | $34 |
Products named: VRAYLAR, JARDIANCE, NURTEC ODT, TRELEGY ELLIPTA, MOUNJARO, LEQVIO, UBRELVY, BREZTRI.
Industry payments across KY — which companies pay providers there.
